Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.

Finasteride-loaded proniosomes effectively promote hair growth in mice.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

A new method using hyaluronic acid liposomes improves Minoxidil's effectiveness and safety for hair growth treatment.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

PRP is more effective than Minoxidil for reducing hair loss and promoting hair growth.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Current treatments for alopecia show no significant long-term benefits.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

No cure for female pattern hair loss, but various effective treatments exist.